chills/fatigue

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 385 rezilta yo

An examination of the working case definition of chronic fatigue syndrome.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Chronic fatigue syndrome (CFS) currently is defined by a working case definition developed under the leadership of the United States Centers for Disease Control and Prevention (CDC) based on a consensus among experienced clinicians. We analyzed the experience from one large center to

[Effects of Piper longum L. on chills in Japanese young women: time-dependent changes in skin surface temperature and its recovery rate following the exposure to mild cold stress].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Chills can lead to problems such as insomnia, mental fatigue, and unstable emotions. Increasing evidence shows that young women, as well as menopausal women, suffer from chills. The present study investigated the effect of Piper longum L. on chills in young women. Participants with (n = 16) and

Chronic fatigue syndrome.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The chronic fatigue syndrome is an illness of unknown etiology characterized by severe fatigue, myalgias, lymphadenopathy, arthralgias, chills, fevers, and postexertional malaise. Recognizing chronic fatigue syndrome is primarily a method of exclusion with no definitive diagnostic test or physical

Chronic fatigue syndrome.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Is fatigue all in your head? A critical review of the central governor model.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The central governor model has recently been proposed as a general model to explain the phenomenon of fatigue. It proposes that the subconscious brain regulates power output (pacing strategy) by modulating motor unit recruitment to preserve whole body homoeostasis and prevent catastrophic

Chronic fatigue syndrome: evaluation and treatment.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Severe fatigue is a common complaint among patients. Often, the fatigue is transient or can be attributed to a definable organic illness. Some patients present with persistent and disabling fatigue, but show no abnormalities on physical examination or screening laboratory tests. In these cases, the

Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Fatigue is one of the most common and disabling symptoms in Parkinson's disease (PD). Since fatigue was first described as a common feature of PD 20 years ago, little progress has been made in understanding its causes or treatment. Importantly, PD patients attending the 2013 World Parkinson Congress

Retrospective Descriptive Analysis of West Nile Neuroinvasive Disease (WNND) in Northwest Louisiana

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Aims: The aim of the study was to describe the presentation characteristics and epidemiology of WNND in Louisiana to improve future recognition of cases and decrease inappropriate antibiotic use. Settings and Design. It was a

Phlegmonous Gastritis in a Bariatric Patient After Sleeve Gastrectomy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Phlegmonous gastritis is a rare and progressive fatal condition that affects the mucosa and submucosa of the gastric wall. It can be localized or diffuse, affecting the entire stomach. It usually presents with upper gastrointestinal symptoms, such as nausea, vomiting, and hematemesis, along with

Rare acute kidney injury secondary to hypothyroidism-induced rhabdomyolysis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Acute kidney injury (AKI) caused by hypothyroidism-induced rhabdomyolysis is a rare and potentially life-threatening syndrome. The aim of this study was to investigate the clinical characteristics of such patients. METHODS We retrospectively analyzed five patients treated at the Second

Cross-sectional community survey of menopause symptoms among Japanese women.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To determine the prevalence and characteristics of climacteric symptoms and related factors among 50-year-old Japanese women. METHODS A self-administered questionnaire was mailed to all 50-year-old women (n=3166) in three northern wards of Kawasaki City regarding 10 menopausal symptoms

Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Twenty-six patients with advanced cancer refractory to standard therapy were treated with recombinant human tumor necrosis factor (rTNF) in a study aimed at determining the toxicity and tolerance of rTNF and at seeking evidence of antitumor activity. The study design involved two treatments per week

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To report the preliminary results of a Phase I/II study combining radiotherapy and in situ gene therapy (adenovirus/herpes simplex virus thymidine kinase gene/valacyclovir) with or without hormonal therapy in the treatment of prostate cancer. METHODS Arm A: low-risk patients (T1-T2a,

Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE The aim of this study was to investigate the efficacy and safety of intraperitoneal catumaxomab in heavily pretreated patients with chemotherapy-refractory ovarian cancer and recurrent symptomatic malignant ascites. METHODS The study is a single-arm open-label multicenter US phase II

Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferon.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

24 patients with advanced, histologically proven cancer were treated with difluoromethylornithine 2.25 g/m2 orally every 6 h for the first 7 days of each 4-week treatment cycle. These patients also received daily i.m. doses of recombinant human alpha 2a-interferon (IFN) on Days 3 through 7 of each

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye